Fátima Duarte
University of Lisbon
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fátima Duarte.
Asia Pacific Allergy | 2017
Rita Aguiar; Fátima Duarte; Ana Mendes; Borja Bartolomé; Manuel Pereira Barbosa
Honey allergy is a very rare, but serious health condition. In this study, we presented 1 patient who had anaphylaxis after the honey allergological investigation with skin prick-prick test with honey. Honey as a food has been associated to allergic reactions and as the increased consumption of honey in health food may increase the incidence of honey-related allergic reactions.
Clinical and Translational Allergy | 2015
Fátima Duarte; A.C.F.M. Costa; Manuel Pereira Barbosa; Maria Conceição Pereira Santos
Material and methods We selected 55 pts (34M, 21F; average age:7.4 years). All had fish allergy, characterized by positive clinical history, skin-prick tests and serum specific IgE to several fish and Gad c 1 (UniCap, Thermo-Fisher). Oral food challenge was performed to evaluate fish tolerance acquisition. Statistical analysis was performed using GraphPad Prisma version 5.0 (GraphPad Software Inc, SD). Two groups were compared using a paired t test Wilcoxon. P values<0.05 were considered significant.
Clinical and Translational Allergy | 2015
João Marcelino; Rita Aguiar; Fátima Duarte; A.C.F.M. Costa; Manuel Pereira-Barbosa
Eosinophilic esophagitis (EoE) is a clinicopathologic entity defined by symptoms of esophageal dysfunction and histological eosinophil (eos) inflammation. Its patients (pts) commonly present concurrent reactivity to both food and aeroallergens, outlining the importance of an allergological evaluation.
World Allergy Organization Journal | 2014
Rita Aguiar; Pedro Eduardo Almeida da Silva; Fátima Duarte; Ana Mendes; A.C.F.M. Costa; Manuel Pereira Barbosa
Methods We retrospectively analyzed the clinical files of all pediatric pts treated with omalizumab from December 2009 to July 2013. The evaluated parameters included: adverse reactions to omalizumab, clinical evolution, Asthma Control Test (ACT) and Severity Scoring of Atopic Dermatitis (SCORAD) score evolution and medication decrease. Statistical significance was defined by a p value in the appropriate nonparametric test lower than 0.05.
World Allergy Organization Journal | 2014
A.C.F.M. Costa; Fátima Duarte; Elisa Pedro; Alcinda Campos Melo; Manuel Pereira Barbosa; Conceição Pereira Santos
Background Peach allergy is prevalent, persistent and potentially severe. LTPs (Pru p 3) and profilins (Pru p 4) are the main allergens involved in this kind of allergy in patients(pts) of Mediterranean area. The hidden presence of LTPs in foodstuffs and in other food involved in LTP syndrome can trigger severe reactions, including anaphylaxis. Thus, this type of allergy can be considered an important target for specific immunotherapy(IT).
Clinical and Translational Allergy | 2014
Rita Aguiar; Pedro Eduardo Almeida da Silva; Fátima Duarte; Ana Mendes; A.C.F.M. Costa; Manuel Barbosa Pereira
Omalizumab is a monoclonal antibody approved for the treatment of severe allergic asthma for patineis above 6 years old in Europe, but its use has been described successfully in other IgE-mediated diseases.
Asia Pacific Allergy | 2018
Cristina Ornelas; Fátima Duarte; Maria Conceição Pereira Santos; Manuel Pereira Barbosa
Revista da Sociedade Portuguesa de Dermatologia e Venereologia | 2018
Ângela Lee Chin; Sara Carvalho; Fátima Duarte; Manuel Pereira Barbosa
The Journal of Allergy and Clinical Immunology | 2016
Rita Aguiar; Ana M. Mendes; A.C.F.M. Costa; Fátima Duarte; Estrella Alonso; Anabela Lopes; Elisa Pedro; Manuel Pereira-Barbosa
Revista Portuguesa de Saúde Pública | 2015
Fátima Duarte; Florentino Serranheira